enzastaurin has been researched along with 7-aminoactinomycin d in 1 studies
Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (7-aminoactinomycin d) | Trials (7-aminoactinomycin d) | Recent Studies (post-2010) (7-aminoactinomycin d) |
---|---|---|---|---|---|
188 | 52 | 99 | 211 | 3 | 47 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dudek, AZ; Jasinski, P; Terai, K; Zwolak, P | 1 |
1 other study(ies) available for enzastaurin and 7-aminoactinomycin d
Article | Year |
---|---|
Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C.
Topics: Annexin A5; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 3; Caspase 9; Cell Survival; Cytosol; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gamma Rays; Humans; Indoles; Phosphorylation; Protein Kinase C; Radiation-Sensitizing Agents; Repressor Proteins; Tumor Cells, Cultured | 2008 |